| scholarly article | Q13442814 |
| P50 | author | Christa W Habela | Q114415529 |
| Guo-Li Ming | Q46050523 | ||
| Hongjun Song | Q46050928 | ||
| P2860 | cites work | Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice | Q48835247 |
| Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia | Q49077733 | ||
| Disrupted small-world networks in schizophrenia. | Q52585363 | ||
| Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. | Q54420423 | ||
| Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics | Q72690265 | ||
| [Induction of pluripotent stem cells from mouse fibroblast cultures] | Q79415623 | ||
| Autism | Q86053508 | ||
| Synaptic density in human frontal cortex — Developmental changes and effects of aging | Q41485344 | ||
| Synaptic dysregulation in a human iPS cell model of mental disorders | Q41534293 | ||
| Opposing microRNA families regulate self-renewal in mouse embryonic stem cells | Q41583993 | ||
| Excess mortality of schizophrenia. A meta-analysis | Q41728228 | ||
| Dopaminergic differentiation of schizophrenia hiPSCs | Q42331751 | ||
| Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders | Q43246437 | ||
| Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex | Q44167711 | ||
| Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks | Q46083730 | ||
| Localized enlargement of the frontal cortex in early autism | Q46265687 | ||
| Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia | Q46522388 | ||
| Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. | Q46970598 | ||
| Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells | Q47788549 | ||
| Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. | Q48087777 | ||
| The synaptic hypothesis of schizophrenia. | Q48249154 | ||
| Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. | Q48256427 | ||
| Childhood onset schizophrenia: cortical brain abnormalities as young adults | Q48383343 | ||
| Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity | Q48615018 | ||
| Induction of pluripotent stem cells from fibroblast cultures | Q48770547 | ||
| A systematic review of the prevalence of schizophrenia | Q21144720 | ||
| Definition and description of schizophrenia in the DSM-5 | Q22251472 | ||
| Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Autism | Q24629445 | ||
| Modelling schizophrenia using human induced pluripotent stem cells | Q24633007 | ||
| Signaling mechanisms regulating adult neural stem cells and neurogenesis | Q24633503 | ||
| Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia | Q24646206 | ||
| Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice | Q24651541 | ||
| Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits | Q24657867 | ||
| Reduced dendritic spine density in auditory cortex of subjects with schizophrenia | Q24658134 | ||
| Understanding synapses: past, present, and future | Q26269897 | ||
| Autism as a neural systems disorder: a theory of frontal-posterior underconnectivity | Q26864589 | ||
| Impact of prenatal environmental stress on cortical development | Q27022274 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex | Q28138248 | ||
| Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies | Q28190066 | ||
| Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits | Q28246677 | ||
| Synaptic, transcriptional and chromatin genes disrupted in autism | Q28250800 | ||
| A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder | Q28254976 | ||
| Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia | Q28274064 | ||
| Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology | Q28294217 | ||
| SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients | Q28300343 | ||
| Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis | Q28303010 | ||
| DISC1: Structure, Function, and Therapeutic Potential for Major Mental Illness | Q28393891 | ||
| Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model | Q28477225 | ||
| Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain | Q28507787 | ||
| Adult Mammalian Neural Stem Cells and Neurogenesis: Five Decades Later | Q38597817 | ||
| Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes | Q28750802 | ||
| FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders | Q28973611 | ||
| Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes | Q29614341 | ||
| NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders | Q29617936 | ||
| Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia | Q29618963 | ||
| A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells | Q29619964 | ||
| Animal models of schizophrenia. | Q30462828 | ||
| A prospective study of the emergence of early behavioral signs of autism | Q30496129 | ||
| Structural Gray Matter Differences During Childhood Development in Autism Spectrum Disorder: A Multimetric Approach | Q30568972 | ||
| Alteration in basal and depolarization induced transcriptional network in iPSC derived neurons from Timothy syndrome. | Q30596522 | ||
| Altered white matter connectivity as a neural substrate for social impairment in Autism Spectrum Disorder. | Q30872464 | ||
| Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan. | Q30936678 | ||
| Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia | Q32000373 | ||
| Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. | Q32063419 | ||
| A cross-laboratory comparison of expression profiling data from normal human postmortem brain | Q33530007 | ||
| Longitudinal changes in cortical thickness in autism and typical development | Q33654230 | ||
| Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders. | Q33733359 | ||
| Convergence of genes and cellular pathways dysregulated in autism spectrum disorders | Q33794546 | ||
| Longitudinal magnetic resonance imaging study of cortical development through early childhood in autism | Q33808718 | ||
| Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder | Q33904544 | ||
| iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth | Q33919340 | ||
| Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia | Q34017293 | ||
| Reprogramming of T cells from human peripheral blood | Q34034432 | ||
| The familial risk of autism | Q34040809 | ||
| Reprogramming of human peripheral blood cells to induced pluripotent stem cells | Q34048915 | ||
| Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome | Q34056154 | ||
| Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. | Q34084795 | ||
| Extraordinary neoteny of synaptic spines in the human prefrontal cortex. | Q34203392 | ||
| Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents | Q34274859 | ||
| Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse | Q34321656 | ||
| Age-related temporal and parietal cortical thinning in autism spectrum disorders | Q34372964 | ||
| Structural plasticity: mechanisms and contribution to developmental psychiatric disorders | Q34442643 | ||
| Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons | Q34469459 | ||
| Glutamatergic mechanisms in schizophrenia | Q34504043 | ||
| De novo mutations in schizophrenia implicate synaptic networks | Q34540372 | ||
| Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity | Q34540416 | ||
| Generation of human induced pluripotent stem cells from dermal fibroblasts | Q34588555 | ||
| Modeling human cortical development in vitro using induced pluripotent stem cells | Q34639912 | ||
| Use of rabies virus as a transneuronal tracer of neuronal connections: implications for the understanding of rabies pathogenesis. | Q34797259 | ||
| Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation | Q34955419 | ||
| Genetics of autism spectrum disorders. | Q34974394 | ||
| Meta-analysis of gene coexpression networks in the post-mortem prefrontal cortex of patients with schizophrenia and unaffected controls | Q34999939 | ||
| Longitudinal volumetric brain changes in autism spectrum disorder ages 6-35 years | Q35130650 | ||
| The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies | Q35186635 | ||
| Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons | Q35593898 | ||
| MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del. | Q35691087 | ||
| Brain growth across the life span in autism: Age-specific changes in anatomical pathology | Q35846553 | ||
| Altered WNT Signaling in Human Induced Pluripotent Stem Cell Neural Progenitor Cells Derived from Four Schizophrenia Patients | Q35904650 | ||
| Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders | Q35956872 | ||
| Neurodevelopmental model of schizophrenia: update 2012 | Q36417310 | ||
| The anatomical distance of functional connections predicts brain network topology in health and schizophrenia | Q36443990 | ||
| DISC1 genetics, biology and psychiatric illness | Q36634401 | ||
| Disrupted axonal fiber connectivity in schizophrenia | Q36938842 | ||
| Glycine transport inhibitors and the treatment of schizophrenia | Q37033084 | ||
| Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation | Q37734466 | ||
| New views of Arc, a master regulator of synaptic plasticity | Q37833492 | ||
| Synaptic changes in the brain of subjects with schizophrenia. | Q37850530 | ||
| Modeling neurological diseases using patient-derived induced pluripotent stem cells | Q37897966 | ||
| Structural plasticity upon learning: regulation and functions. | Q38020090 | ||
| Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders | Q38053656 | ||
| WNT signaling in neuronal maturation and synaptogenesis | Q38121069 | ||
| The genetic landscapes of autism spectrum disorders | Q38123219 | ||
| Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches. | Q38133757 | ||
| AMPARs and synaptic plasticity: the last 25 years | Q38158723 | ||
| The synapse in schizophrenia | Q38203024 | ||
| Functions and dysfunctions of adult hippocampal neurogenesis | Q38218218 | ||
| Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia | Q38268878 | ||
| Closing the translational gap between mutant mouse models and the clinical reality of psychotic illness. | Q38330255 | ||
| Glutamate synapses in human cognitive disorders | Q38432878 | ||
| Modeling hippocampal neurogenesis using human pluripotent stem cells | Q38460557 | ||
| P921 | main subject | autism | Q38404 |
| schizophrenia | Q41112 | ||
| P304 | page(s) | 52-62 | |
| P577 | publication date | 2015-12-02 | |
| P1433 | published in | Molecular and Cellular Neuroscience | Q6895985 |
| P1476 | title | Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons | |
| P478 | volume | 73 |
| Q28079929 | A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons. |
| Q92799609 | Biophysical Psychiatry-How Computational Neuroscience Can Help to Understand the Complex Mechanisms of Mental Disorders |
| Q46976609 | Cellular Phenotypes in Human iPSC-Derived Neurons from a Genetic Model of Autism Spectrum Disorder |
| Q41841616 | Cellular Zinc Homeostasis Contributes to Neuronal Differentiation in Human Induced Pluripotent Stem Cells |
| Q58577750 | Complete Disruption of Autism-Susceptibility Genes by Gene Editing Predominantly Reduces Functional Connectivity of Isogenic Human Neurons |
| Q104111273 | Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients |
| Q41665354 | Cross Talk: The Microbiota and Neurodevelopmental Disorders |
| Q42508604 | Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson's disease. |
| Q50420073 | Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children |
| Q91867157 | Early Actions of Neurotransmitters During Cortex Development and Maturation of Reprogrammed Neurons |
| Q92460272 | Haploinsufficiency in the ANKS1B gene encoding AIDA-1 leads to a neurodevelopmental syndrome |
| Q91341535 | Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning |
| Q60958413 | Modeling Inflammation in Autism Spectrum Disorders Using Stem Cells |
| Q95270886 | Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia |
| Q57800211 | Oligodendrocyte differentiation of induced pluripotent stem cells derived from subjects with schizophrenias implicate abnormalities in development |
| Q53426251 | Recurrent reciprocal copy number variants: Roles and rules in neurodevelopmental disorders. |
| Q64093176 | The Protracted Maturation of Associative Layer IIIC Pyramidal Neurons in the Human Prefrontal Cortex During Childhood: A Major Role in Cognitive Development and Selective Alteration in Autism |
| Q99418604 | Transcription factor POU3F2 regulates TRIM8 expression contributing to cellular functions implicated in schizophrenia |
| Q90423767 | Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell-Derived Cerebral Organoids in Schizophrenia |
| Q28074740 | Wnt signaling networks in autism spectrum disorder and intellectual disability |
| Q61796583 | or human iPSC-derived neurons from individuals with autism develop hyperactive neuronal networks |
Search more.